3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
34
Phase 1/2
25
Phase 1
22
Phase NA
7
Phase EARLY_PHASE1
3
Phase 3
3
Phase 4
2
Phase 2/3
1
Status
Completed
10
Unknown
5
Terminated
3
Recruiting
3
Not yet recruiting
3
Withdrawn
2
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Dermatologic
2
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
10
Neoplasms
9
Polycystic Ovary Syndrome
8
Infertility
5
Liver Neoplasms
4
Pain, Postoperative
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Recurrence
2
Pulmonary Embolism
2
Prostatic Neoplasms
2
Pleural Effusion
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neuroma, Acoustic
2
Melanoma
2
Lymphoma, Follicular
2
Leiomyoma
2
Inflammation
2
Febrile Neutropenia
2
Colorectal Neoplasms
2
Bites and Stings
2
Anovulation
2
Vomiting
1
Venous Thrombosis
1
Venous Thromboembolism
1
Interventions
encorafenib
1
binimetinib
1
Patient-Specific Modeling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Withdrawn
×
Melanoma
×
Clear all
NCT07092410
2026-04-21
SuRage-EB
SRH Wald-Klinikum Gera GmbH
Phase 4
Withdrawn
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn